Assessment of atherosclerotic risk, in young, non-obese women with female pattern hair loss
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 58
- 试验地点
- 1
- 主要终点
- 1.To estimate the plasma levels of CRP, HDL & triglycerides, and calculate the atherogenic index
研究概览
简要总结
Androgenetic alopecia (AGA) in women, also commonlyknown as Female pattern hair loss (FPHL) is a nonscarring progressive thinningof hair, particularly in the frontal, central, and parietal scalp, as a resultof follicular miniaturisation. Numerous studies have demonstratedthe unavoidable connection between androgenetic alopecia in males and coronaryartery disease. However, a paucity of similar studies in womencalls for the need to know a similar association.
Corelating, different grades of FPHL with the severityof atherosclerosis in healthy, young, non-obese women, would help in isolatingwomen who are prone to developing coronary artery disease (CAD). There isabundance of evidence to prove the relationship between concentrations oflipids and lipoproteins with the development of CAD leading to ischaemic heartdisease. It has been demonstrated that estimating the atherogenic index, or thelog of the ratio of triglycerides to high-density lipoproteins (HDL), is asuperior predictor of cardiovascular events.
Numerous circulating markers of inflammation have beenstudied for their potential to forecast the risk of vascular events becausethere is a wealth of evidence linking inflammation to atherosclerosis and acutecoronary syndromes (ACS). The biomarker that is most researched in this contextis C-reactive protein. It is a prognostic indicator for cardiovascularmortality and recurrence for both primary and secondary protection.
Additionally, estimation of Epicardial Adipose Tissue (EAT)Thickness provides a major indicator of atherosclerosis linked tocardiovascular risk factors and outcomes.
This study wouldhelp in identifying young women who otherwise do not have any disease and arestill prone to developing CAD. Diagnosing FPHL and correlating it withatherogenic potential would be a non-invasive way to diagnose CAD earlier.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)(—)
- 性别
- Female
入选标准
- •1.All FPHL cases with a clinical diagnosis who agree to take part in the research.
排除标准
- •1.Diffuse hair loss with physiological reasons, such as pregnancy or breastfeeding.
- •2.Patients taking chronic corticosteroid treatment, hormonal replacement therapy, or contraceptives.
- •3.Disorders of lipid metabolism or use of medications that could have an impact on lipids.
- •4.Other causes of alopecia including scarring and non-scarring alopecia 5.Patients with a family history of cardiovascular diseases (CVD).
- •6.Patients having any inflammatory condition likely to cause a raised CRP.
结局指标
主要结局
1.To estimate the plasma levels of CRP, HDL & triglycerides, and calculate the atherogenic index
时间窗: At baseline
2.To measure the Epicardial Adipose Tissue (EAT) thickness using Echocardiography.
时间窗: At baseline
3.To correlate atherosclerosis with different grades of FPHL
时间窗: At baseline
次要结局
未报告次要终点
